LHC Group Receives Outperform Rating from Oppenheimer (LHCG)
LHC Group (NASDAQ:LHCG)‘s stock had its “outperform” rating restated by equities researchers at Oppenheimer in a research report issued on Friday. They currently have a $27.00 price objective on the stock, up from their previous price objective of $26.00. Oppenheimer’s price target would suggest a potential upside of 11.89% from the company’s current price.
Shares of LHC Group (NASDAQ:LHCG) opened at 24.13 on Friday. LHC Group has a 52 week low of $19.69 and a 52 week high of $26.43. The stock’s 50-day moving average is $21.96 and its 200-day moving average is $21.94. The company has a market cap of $416.3 million and a price-to-earnings ratio of 19.95.
LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, August 6th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.03. The company had revenue of $188.90 million for the quarter, compared to the consensus estimate of $179.90 million. During the same quarter last year, the company posted $0.34 earnings per share. LHC Group’s revenue was up 13.6% compared to the same quarter last year. Analysts expect that LHC Group will post $1.23 EPS for the current fiscal year.
LHC Group, Inc (NASDAQ:LHCG) provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals (LTACHs).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with Analyst Ratings Network's FREE daily email newsletter.